Literature DB >> 3771624

Frequency distribution of tissue mast cells and eosinophilic granulocytes in tumor-draining axillary and paracolic lymph nodes.

H P Horny, H A Horst.   

Abstract

The frequency distribution of tissue mast cells and eosinophilic granulocytes in tumor-draining lymph nodes was evaluated. In total 483 axillary lymph nodes draining invasive ductal breast cancer and 162 paracolic lymph nodes draining infiltrating adenocarcinoma of the large bowel were analyzed. Significantly higher number of sinus mast cells were found in axillary lymph nodes as compared with the paracolic ones whereas eosinophilic granulocytes were more frequent in paracolic than in axillary lymph nodes. Concerning both cell systems no significant differences could be demonstrated when all lymph nodes from nodal-negative cases were compared with the lymph nodes from cases with regional lymph node metastases. Tumor-free axillary lymph nodes, however, showed a significantly higher mast cell content in the sinus and medulla than did lymph nodes bearing metastases. The number of eosinophilic granulocytes did not differ in either lymph node group.

Entities:  

Mesh:

Year:  1986        PMID: 3771624     DOI: 10.1007/bf00404399

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  [ON THE SELECTIVE ENZYME-CYTOCHEMICAL DEMONSTRATION OF NEUTROPHILIC MYELOID CELLS AND TISSUE MAST CELLS IN PARAFFIN SECTIONS].

Authors:  L D LEDER
Journal:  Klin Wochenschr       Date:  1964-06-01

2.  The eosinophil and gastrointestinal carcinoma.

Authors:  I L YOON
Journal:  Am J Surg       Date:  1959-02       Impact factor: 2.565

3.  Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

Authors:  A B Kay; J M McVie; A E Stuart; A Krajewski; L W Turnbull
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

4.  Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro- and macrometastases.

Authors:  E R Fisher; A Palekar; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

5.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons.

Authors:  R Bedwani; J Vana; D Rosner; R L Schmitz; G P Murphy
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

7.  Paracortical activity of the regional lymph nodes as a prognostic determinant in gastric carcinoma.

Authors:  K J Syrjänen; L H Hjelt
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

8.  [Hypereosinophilia in cancer and cirrhosis : utility of total eosinophil count (author's transl)].

Authors:  C Noirot; F Leynadier; H Luce; N Abuaf; P F Bernard; J Dry
Journal:  Sem Hop       Date:  1982-01-21

9.  Tumor-host relationships in colorectal carcinoma.

Authors:  K J Syrjänen; L H Hjelt
Journal:  Dis Colon Rectum       Date:  1978 Jan-Feb       Impact factor: 4.585

10.  Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system.

Authors:  W R Henderson; E Y Chi; E C Jong; S J Klebanoff
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  2 in total

1.  Conjugated linoleic acid induces mast cell recruitment during mouse mammary gland stromal remodeling.

Authors:  Joshua S Russell; Sibel Oflazoglu McGee; Margot M Ip; Dietrich Kuhlmann; Patricia A Masso-Welch
Journal:  J Nutr       Date:  2007-05       Impact factor: 4.798

2.  Distribution of Mast Cells in Mediastinal Lymph Nodes from Lung Cancer Patients.

Authors:  Masaki Tomita; Yasunori Matsuzaki; Masao Edagawa; Tetsuya Shimizu; Masaki Hara; Toshio Onitsuka
Journal:  World J Surg Oncol       Date:  2003-11-18       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.